Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze TVTX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TVTX investment potential.

What is TVTX stock price today?

Get real-time TVTX stock price, historical data, and price charts on Financhill. Track TVTX performance with our advanced analysis tools.

Is TVTX a good investment?

Evaluate TVTX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TVTX stock?

To buy TVTX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TVTX?

View detailed market capitalization data and company valuation metrics for TVTX on our comprehensive analysis page.

What is the P/E ratio of TVTX?

Use our fundamental analysis tools to view TVTX P/E ratio and compare valuation metrics with industry peers.

What are TVTX earnings?

View TVTX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Travere Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

TVTX
Travere Therapeutics, Inc.

Last Price:

$30.4000

Seasonality Move:

-9.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Travere Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Travere Therapeutics, Inc. has on average historically risen by 663.6% based on the past 19 years of stock performance.
Travere Therapeutics, Inc. has risen higher in 9 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.37%
Is Travere Therapeutics, Inc. Stock Undervalued?

The current Travere Therapeutics, Inc. [TVTX] share price is $29.3500. The Score for TVTX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
TVTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Travere Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Travere Therapeutics, Inc. has on average historically risen by 663.6% based on the past 19 years of stock performance.

Travere Therapeutics, Inc. Stock Rating

Buy

Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. overpriced?

Travere Therapeutics, Inc. has risen higher in 9 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.37%

Travere Therapeutics, Inc. Stock Price History

Is TVTX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

travere.com

52-Week Data

52-Week High:

42.1300

52-Week Low:

12.9100

Prediction Charts

Market Cap:

2.6B

Price in USD:

29.3500

Volume:

2.6M

Beta:

52.6173

Technical Analysis

SMA50:

32.8377

SMA100:

31.8310

SMA200:

24.7854

52-Wk Change:

25.8%

Stock Predictions

Is Travere Therapeutics, Inc. stock public?

Yes, Travere Therapeutics, Inc. is a publicly traded company.
What is the Travere Therapeutics, Inc. stock quote today?

The Travere Therapeutics, Inc. stock price is 29.3500 USD today.
How to buy Travere Therapeutics, Inc. stock online?

You can buy Travere Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jan-30	31.5700	31.1100	31.9600	30.6900
Feb-2	31.0900	33.0950	33.1350	31.0400
Feb-3	32.8700	32.8500	33.0100	31.5000
Feb-4	32.8000	31.6800	32.9000	30.8200
Feb-5	31.6700	29.4600	32.7200	29.3100
Feb-6	29.9100	29.7000	30.6500	29.4500
Feb-9	29.6800	30.0700	30.3600	28.9000
Feb-10	30.1200	30.3400	30.6500	29.6300
Feb-11	30.1700	30.2200	30.6000	29.1200
Feb-12	30.5900	30.6000	30.9900	29.9400
Feb-13	30.6000	27.8200	31.4400	27.2500
Feb-17	27.8300	28.7500	28.8450	27.0100
Feb-18	28.0900	27.8700	29.4950	27.7500
Feb-19	27.9500	29.3500	29.3700	27.9000

Travere Therapeutics, Inc. Earnings

Travere Therapeutics, Inc. Earnings Report: Per Share Travere Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Travere Therapeutics, Inc. Forecast Revenue Growth

Travere Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Travere Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.04 per share, and an increase next year of $1.49 per share.

* Travere Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.